Publication | Open Access
Protocol of DREAM3R: DuRvalumab with chEmotherapy as first-line treAtment in advanced pleural Mesothelioma—a phase 3 randomised trial
28
Citations
17
References
2022
Year
ClinicalTrials.gov Identifier: NCT04334759 ACTRN 12620001199909.
| Year | Citations | |
|---|---|---|
Page 1
Page 1